Gerstner Sloan-Kettering - Graduate School of Biomedical Sciences
Return to Formatted Version
Faculty/Research

Special Contributing Faculty

Faculty members who do not serve as dissertation mentors but who make contributions to the education of our students by teaching or serving as clinical mentors are appointed as Gerstner Sloan-Kettering Special Contributing Faculty.

The following is a list of current members of the contributing faculty along with their research interests:

  • Marinela Capanu
    Epidemiology and Biostatistics
    Hierarchical models in genetic association studies, misspecification tests, and survival analysis.

  • Timothy Chan
    Human Oncology and Pathogenesis
    Genetic changes that underlie the development of glioblastoma.

  • Maura N. Dickler
    Medicine
    Hormonal therapy and anti-angiogenic therapy of breast cancer.

  • Clifford A. Hudis
    Medicine
    Translational clinical trials for breast cancer.

  • Joseph G. Jurcic
    Medicine
    Acute myeloid leukemia, monoclonal antibodies, and radioimmunotherapy.

  • John Humm
    Medical Physics
    Molecular imaging of cancer by PET, hypoxia, and targeted radionuclide therapies, especially with tumor-specific antibodies.

  • David S. Klimstra
    Pathology
    Pathology of pancreatic, hepatobiliary, and gastrointestinal neoplasia.

  • Mark G. Kris
    Medicine
    Clinical trials and translational research.

  • Andrew B. Lassman
    Neurology
    Translational research in brain tumors.

  • Robert J. Motzer
    Medicine
    Clinical trials for metastatic renal cell carcinoma and germ cell tumors.

  • Larry Norton
    Medicine
    Breast Cancer clinical trials, tumor growth kinetics, and mathematics of metastasis.

  • Philip B. Paty
    Surgery
    Biomarkers -- diagnostic, prognostic, predictive -- for colorectal cancer.

  • Victor E. Reuter
    Pathology
    Marker evaluation and validation in urologic cancers.

  • Leonard Saltz
    Medicine
    Development of new therapies for colorectal cancer.

  • Howard I. Scher
    Medicine
    Mechanism-based drug development for prostate cancer.

  • Archie N. Tse
    Medicine
    Regulation of cell cycle checkpoint and development of checkpoint inhibitors for cancer therapy.

  • Agnes Viale
    Genomics Core
    Genomics: from microarrays to next generation sequencing.

  • Jedd Wolchok
    Medicine
    Development and application of novel immunotherapy.

  • Nian Wu
    Molecular Pharmacology & Chemistry
    Analytical pharmacology/toxicology, bioassay, and drug-delivering technology.

  • Pat Zanzonico
    Medical Physics
    Nuclear medicine and molecular imaging research: hypoxia imaging, targeted radionuclide therapy, and small-animal imaging.

  • Andrew D. Zelenetz
    Medicine
    Clinical and translation research in lymphoma.

  • Kristen Zakian
    Medical Physics
    Magnetic resonance imaging and spectroscopy to study cancer.

Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences
©2009 Memorial Sloan-Kettering Cancer Center